• 4D Molecular Therapeutics (NASDAQ:FDMT) Earns "Buy" Rating from HC Wainwright

    Source: Buzz FX / 03 Mar 2025 08:02:15   America/Chicago


    4D Molecular Therapeutics (NASDAQ:FDMT) Earns "Buy" Rating from HC Wainwright Written by MarketBeat March 3, 2025 Share Link copied to clipboard. 4D Molecular Therapeutics ( NASDAQ:FDMT - Get Free Report ) 's stock had its "buy" rating rest
    Read more...
Share on,